Introduction The Raloxifene Market is gaining increasing attention in the global pharmaceutical landscape due to the growing prevalence of osteoporosis and postmenopausal disorders among women. Raloxifene, a selective estrogen receptor modulator (SERM), is primarily used for the prevention and treatment of osteoporosis in postmenopausal women and for reducing the risk of invasive breast...